{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:38:45Z","timestamp":1768963125401,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cbi.2024.111265","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T22:55:04Z","timestamp":1728687304000},"page":"111265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and in vivo"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9526-6749","authenticated-orcid":false,"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hualu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5046-9806","authenticated-orcid":false,"given":"Ruanjuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111265_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s11010-022-04376-6","article-title":"Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review","volume":"477","author":"Kumar","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2024.111265_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010119","article-title":"Towards comprehension of the ABCB1\/P-glycoprotein role in chronic myeloid leukemia","volume":"23","author":"Maia","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111265_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/bloodadvances.2019000268","article-title":"Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia","volume":"4","author":"Chan","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.cbi.2024.111265_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1055\/s-0039-1688787","article-title":"Ponatinib tyrosine kinase inhibitor induces a thromboinflammatory response","volume":"119","author":"Hamadi","year":"2019","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.cbi.2024.111265_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41408-023-00823-9","article-title":"Management of chronic myeloid leukemia in 2023 - common ground and common sense","volume":"13","author":"Senapati","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cbi.2024.111265_bib6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1039\/D0NP00057D","article-title":"Traditional Chinese medicine (TCM) as a source of new anticancer drugs","volume":"38","author":"Yao","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.cbi.2024.111265_bib7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2174\/156802610792928103","article-title":"Reversal of multidrug resitance by natural substances from plants","volume":"10","author":"Moln\u00e1r","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111265_bib8","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese medicine for cardiovascular disease: Evidence and potential mechanisms","volume":"69","author":"Hao","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2024.111265_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235152","article-title":"The anti-cancer activity of lycopene: a systematic review of human and animal studies","volume":"14","author":"Kapa\u0142a","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2024.111265_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153805","article-title":"Shikonin, a naphthalene ingredient: therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches","volume":"94","author":"Sun","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.111265_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103235","article-title":"Cardiovascular disease and possible ways in which lycopene acts as an efficient cardio-protectant against different cardiovascular risk factors","volume":"27","author":"Hsieh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111265_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fitote.2016.07.010","article-title":"Modulation of plasminogen activator inhibitor-1 (PAI-1) by the naphthoquinone shikonin","volume":"113","author":"Han","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2024.111265_bib13","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1021\/acs.molpharmaceut.7b00257","article-title":"Brain accumulation of ponatinib and its active metabolite, N-desmethyl ponatinib, is limited by P-glycoprotein (P-GP\/ABCB1) and breast cancer resistance protein (BCRP\/ABCG2)","volume":"14","author":"Kort","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2024.111265_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/jcph.109","article-title":"Effects of ketoconazole on the pharmacokinetics of ponatinib in healthy subjects","volume":"53","author":"Narasimhan","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111265_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1248\/bpb.35.329","article-title":"Mechanism-based inhibition of recombinant human cytochrome P450 3A4 by tomato juice extract","volume":"35","author":"Sunaga","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2024.111265_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2017.09.014","article-title":"Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay","volume":"281","author":"Tang","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.111265_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2147\/DDDT.S160316","article-title":"Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo","volume":"12","author":"He","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.cbi.2024.111265_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/dmd.117.079152","article-title":"Comparison of species and cell-type differences in fraction unbound of liver tissues, hepatocytes, and cell lines","volume":"46","author":"Riccardi","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2024.111265_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2024.111265_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111265_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanisms of transformation by the BCR-ABL oncogene","volume":"40","author":"Sattler","year":"2003","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cbi.2024.111265_bib22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/14656566.2022.2064742","article-title":"Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia","volume":"23","author":"Haddad","year":"2022","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.cbi.2024.111265_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719826444","article-title":"Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia","volume":"10","author":"Molica","year":"2019","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.cbi.2024.111265_bib24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/ajh.27037","article-title":"Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era","volume":"98","author":"Haddad","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cbi.2024.111265_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186556","article-title":"Ponatinib and other CML tyrosine kinase inhibitors in thrombosis","volume":"21","author":"Zeng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111265_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/ptr.1746","article-title":"Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity","volume":"19","author":"Karimi","year":"2005","journal-title":"Phytother Res."},{"key":"10.1016\/j.cbi.2024.111265_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41598-024-51675-7","article-title":"Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1\/Nrf2 pathway in mice","volume":"14","author":"Tuo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111265_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40487-016-0022-2","article-title":"Liquid chromatography-mass spectrometry\/mass spectrometry analysis and pharmacokinetic assessment of ponatinib in sprague-dawley rats","volume":"4","author":"Wang","year":"2016","journal-title":"Oncol Ther"},{"key":"10.1016\/j.cbi.2024.111265_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2016-09-739086","article-title":"Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial","volume":"132","author":"Cortes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2024.111265_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1017\/S0007114513002730","article-title":"Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"111","author":"Zou","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.cbi.2024.111265_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuro.2020.06.005","article-title":"Lycopene protects against central and peripheral neuropathy by inhibiting oxaliplatin-induced ATF-6 pathway, apoptosis, inflammation and oxidative stress in brains and sciatic tissues of rats","volume":"80","author":"Celik","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2024.111265_bib32","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jphp.13288","article-title":"The inhibitory effects of shikonin and \u03b2,\u03b2-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo","volume":"72","author":"Jin","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111265_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40261-014-0225-y","article-title":"Evaluation of the effect of multiple doses of lansoprazole on the pharmacokinetics and safety of ponatinib in healthy subjects","volume":"34","author":"Narasimhan","year":"2014","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.cbi.2024.111265_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/dmd.105.007625","article-title":"In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancer","volume":"34","author":"Marechal","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2024.111265_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002280100374","article-title":"Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes","volume":"57","author":"Katsuki","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111265_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164967","article-title":"Validated LC-MS\/MS method for the quantification of ponatinib in plasma: application to metabolic stability","volume":"11","author":"Kadi","year":"2016","journal-title":"PLoS One"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:56:49Z","timestamp":1730825809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724004113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"alternative-id":["S0009279724004113"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111265","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of ponatinib metabolism and drug-drug interactions with lycopene and shikonin in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111265"}}